EFG Asset Management North America Corp. grew its stake in shares of Rxo Inc (NYSE:RXO – Free Report) by 42.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 205,089 shares of the company’s stock after purchasing an additional 61,162 shares during the period. EFG Asset Management North America Corp.’s holdings in RXO were worth $3,155,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of RXO. Orbis Allan Gray Ltd boosted its position in RXO by 3.8% during the 2nd quarter. Orbis Allan Gray Ltd now owns 31,375,221 shares of the company’s stock valued at $493,218,000 after acquiring an additional 1,142,710 shares in the last quarter. State Street Corp boosted its position in shares of RXO by 1.5% during the second quarter. State Street Corp now owns 5,821,207 shares of the company’s stock valued at $91,509,000 after purchasing an additional 85,405 shares in the last quarter. Douglas Lane & Associates LLC boosted its position in shares of RXO by 3.4% during the third quarter. Douglas Lane & Associates LLC now owns 3,866,005 shares of the company’s stock valued at $59,459,000 after purchasing an additional 126,227 shares in the last quarter. Geode Capital Management LLC grew its stake in RXO by 4.0% in the second quarter. Geode Capital Management LLC now owns 3,611,478 shares of the company’s stock worth $56,780,000 after purchasing an additional 139,999 shares during the period. Finally, Frontier Capital Management Co. LLC raised its holdings in RXO by 39.6% in the second quarter. Frontier Capital Management Co. LLC now owns 1,801,187 shares of the company’s stock worth $28,315,000 after purchasing an additional 511,036 shares in the last quarter. 92.73% of the stock is owned by institutional investors.
Insider Activity
In related news, Director Troy A. Cooper acquired 8,317 shares of the stock in a transaction that occurred on Thursday, November 20th. The shares were bought at an average price of $10.61 per share, for a total transaction of $88,243.37. Following the completion of the transaction, the director directly owned 275,416 shares in the company, valued at approximately $2,922,163.76. This trade represents a 3.11% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Andrew M. Wilkerson bought 7,775 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was bought at an average price of $12.88 per share, for a total transaction of $100,142.00. Following the acquisition, the chief executive officer directly owned 7,775 shares of the company’s stock, valued at $100,142. The trade was a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 40,250 shares of company stock valued at $488,875 over the last three months. Insiders own 1.48% of the company’s stock.
RXO Trading Down 4.0%
RXO (NYSE:RXO – Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.44 billion. RXO had a positive return on equity of 0.88% and a negative net margin of 1.25%.RXO’s quarterly revenue was up 34.6% compared to the same quarter last year. During the same period last year, the firm posted $0.05 EPS. Sell-side analysts expect that Rxo Inc will post 0.31 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on RXO. Benchmark reaffirmed a “hold” rating on shares of RXO in a research report on Thursday, January 15th. Stifel Nicolaus raised their target price on shares of RXO from $15.00 to $16.00 and gave the company a “hold” rating in a research note on Tuesday, December 16th. Susquehanna boosted their price target on RXO from $10.00 to $11.00 and gave the stock a “negative” rating in a research report on Thursday, January 8th. TD Cowen restated a “hold” rating on shares of RXO in a research note on Friday, January 9th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of RXO in a research note on Monday, December 22nd. Four analysts have rated the stock with a Buy rating, eleven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $16.14.
Get Our Latest Research Report on RXO
RXO Profile
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Read More
- Five stocks we like better than RXO
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Nvidia’s 3 Secret Partners
- The biggest scam in the history of gold markets is unwinding
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
